Mid-Year Healthcare Venture Trends to Watch in 2026 on July 23, 2026 biopharma venture Capital Ecosystem equity Funding Glucagon-Like Peptide 1 Health care facility healthcare IPO healthcare venture healthspan Investments medtech platforms trends qualifier venture +
GE HealthCare Appoints Kevin Lobo to Board of Directors on March 18, 2026 Board Appointment GE HealthCare Kevin Lobo medtech Stryker +
J&J Targets $100 Billion in 2026 Sales Despite Stelara Patent Cliff on January 23, 2026 2026 Darzalex J&J Johnson & Johnson medtech Neoplasms patent cliff Sales - occupational activity Shockwave Medical Stelara +
J&J Brushes Off MFN Impact, Forecasts $100 Billion Revenue Milestone for 2026 on January 21, 2026 Innovative Medicine J&J Johnson & Johnson medtech MFN Projections and Predictions Trump drug pricing +
Pulse Biosciences, Inc. Appoints Maria Sainz to Board of Directors Effective January 9, 2026 on January 13, 2026 Board appointment healthcare technology Maria Sainz medtech nPulse Pulse Biosciences +
Pulse Biosciences, Inc. Appoints Maria Sainz to Board of Directors Effective January 9, 2026 on January 12, 2026 Board appointment healthcare technology Maria Sainz medtech nPulse Pulse Biosciences +
Pulse Biosciences, Inc. Appoints Maria Sainz to Board of Directors Effective January 9, 2026 on January 12, 2026 Board appointment healthcare technology Maria Sainz medtech nPulse Pulse Biosciences +
Solventum Appoints Heather Knight as Chief Commercial Officer on October 22, 2025 Appointments Chief Commercial Officer Chris Barry Dental Solutions Global commercial operations Health Information Systems Heather Knight Leadership MedSurg medtech R&D Solventum +
Johnson & Johnson to Separate Orthopaedics Business on October 14, 2025 DePuy Synthes Diastasis Johnson & Johnson medtech Orthopedics +
Hatteras Raises $200M for Two New Funds Following HistoSonics Exit Success on August 14, 2025 Biological Science Disciplines early-stage Hatteras Hatteras Opportunity Fund I Hatteras Venture Fund VII HistoSonics exit medtech Partner in relationship startups venture capital +
Sofinnova Partners Secures €1.2 Billion for Life Sciences Innovation on March 05, 2025 Capital digital medicine Health care facility Industry medtech sustainability venture +